|
|
Cerebellar level of neurotransmitters in rats exposed to paracetamol during development
|
|
|
|
|
نویسنده
|
blecharz-klin k. ,joniec-maciejak i. ,jawna-zboińska k. ,pyrzanowska j. ,piechal a. ,wawer a. ,widy-tyszkiewicz e.
|
منبع
|
pharmacological reports - 2016 - دوره : 68 - شماره : 6 - صفحه:1159 -1164
|
چکیده
|
Background the present study was designed to clarify the effect of prenatal and postnatal paracetamol administration on the neurotransmitter level and balance of amino acids in the cerebellum. methods biochemical analysis to determine the concentration of neurotransmitters in this brain structure was performed on two-month-old wistar male rats previously exposed to paracetamol in doses of 5 (p5,n = 10) or 15 mg/kg (p15,n = 10) throughout the entire prenatal period,lactation and until the completion of the second month of life,when the experiment was terminated. control animals were given tapped water (con,n = 10). the cerebellar concentration of monoamines,their metabolites and amino acids were assayed using high performance liquid chromatography (hplc). results the present experiment demonstrates that prenatal and postnatal paracetamol exposure results in modulation of cerebellar neurotransmission with changes concerning mainly 5-hiaa and mhpg levels. conclusion the effect of paracetamol on monoaminergic neurotransmission in the cerebellum is reflected by changes in the level of catabolic end-products of serotonin (5-hiaa) and noradrenaline (mhpg) degradation. further work is required to define the mechanism of action and impact of prenatal and postnatal exposure to paracetamol in the cerebellum and other structures of the central nervous system (cns). © 2016 institute of pharmacology,polish academy of sciences
|
کلیدواژه
|
Acetaminophen; Amino acids; Cerebellum; Neurotransmission; Paracetamol
|
آدرس
|
department of experimental and clinical pharmacology,medical university of warsaw,centre for preclinical research and technology cept,warsaw, Poland, department of experimental and clinical pharmacology,medical university of warsaw,centre for preclinical research and technology cept,warsaw, Poland, department of experimental and clinical pharmacology,medical university of warsaw,centre for preclinical research and technology cept,warsaw, Poland, department of experimental and clinical pharmacology,medical university of warsaw,centre for preclinical research and technology cept,warsaw, Poland, department of experimental and clinical pharmacology,medical university of warsaw,centre for preclinical research and technology cept,warsaw, Poland, department of experimental and clinical pharmacology,medical university of warsaw,centre for preclinical research and technology cept,warsaw, Poland, department of experimental and clinical pharmacology,medical university of warsaw,centre for preclinical research and technology cept,warsaw, Poland
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Authors
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|